In addition, individuals using anti-IL-17 mAbs are more likely to develop oropharyngeal, esophageal, and cutaneous candidiasis.111 Mice deficient in IL-17 or its associated receptors showed an increased fungal load following a fungal challenge in mouse models. This evidence concerns the gene IL17A and cutaneous candidiasis.